Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $123.19 | 7 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| EMD Serono, Inc. | $66.30 | 4 | $0 (2019) |
| GE HEALTHCARE | $20.34 | 1 | $0 (2020) |
| Boston Scientific Corporation | $18.71 | 1 | $0 (2020) |
| Genentech USA, Inc. | $17.84 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $39.05 | 2 | GE HEALTHCARE ($20.34) |
| 2019 | $67.67 | 4 | EMD Serono, Inc. ($49.83) |
| 2018 | $16.47 | 1 | EMD Serono, Inc. ($16.47) |
All Payment Transactions
7 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/13/2020 | GE HEALTHCARE | — | Food and Beverage | Cash or cash equivalent | $20.34 | General |
| 02/24/2020 | Boston Scientific Corporation | WATCHMAN (Device) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: STRUCTURAL HEART | ||||||
| 10/28/2019 | EMD Serono, Inc. | Gonal-f (Biological) | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: Reproductive | ||||||
| 09/17/2019 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: Immunology | ||||||
| 07/24/2019 | EMD Serono, Inc. | Gonal-f (Biological) | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: Reproductive | ||||||
| 02/20/2019 | EMD Serono, Inc. | Gonal-f (Biological) | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: Reproductive | ||||||
| 10/29/2018 | EMD Serono, Inc. | Gonal-f (Biological) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: Reproductive | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 677 | 1,659 | $320,380 | $137,885 |
| 2022 | 12 | 922 | 2,069 | $343,999 | $170,002 |
| 2021 | 14 | 926 | 1,992 | $316,906 | $180,723 |
| 2020 | 14 | 1,065 | 2,115 | $286,567 | $145,572 |
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 305 | 809 | $202,250 | $89,848 | 44.4% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 50 | 331 | $59,580 | $24,873 | 41.7% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 26 | 26 | $19,500 | $7,073 | 36.3% |
| 90682 | Influenza vaccine, quadrivalent derived from recombinant dna | Office | 2023 | 75 | 76 | $3,268 | $3,203 | 98.0% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 15 | 60 | $3,900 | $2,812 | 72.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 78 | 80 | $2,400 | $2,352 | 98.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 30 | 36 | $7,560 | $2,191 | 29.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 31 | 33 | $4,917 | $1,765 | 35.9% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 26 | 26 | $2,500 | $1,330 | 53.2% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 27 | 27 | $9,855 | $1,293 | 13.1% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2023 | 14 | 155 | $4,650 | $1,144 | 24.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 323 | 882 | $170,580 | $101,359 | 59.4% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 54 | 325 | $58,500 | $19,882 | 34.0% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2022 | 63 | 63 | $47,250 | $18,438 | 39.0% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2022 | 51 | 204 | $13,260 | $9,883 | 74.5% |
| 90682 | Influenza vaccine, quadrivalent derived from recombinant dna | Office | 2022 | 99 | 102 | $4,386 | $4,303 | 98.1% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2022 | 68 | 68 | $6,650 | $3,515 | 52.9% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2022 | 70 | 70 | $25,550 | $3,480 | 13.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 38 | 41 | $5,880 | $3,333 | 56.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 97 | 100 | $3,000 | $2,832 | 94.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 25 | 27 | $2,673 | $1,487 | 55.6% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2022 | 13 | 165 | $4,950 | $1,275 | 25.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 21 | 22 | $1,320 | $213.67 | 16.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 347 | 967 | $183,730 | $120,114 | 65.4% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Facility | 2021 | 45 | 274 | $40,950 | $18,995 | 46.4% |
About Peter Vaccaro
Peter Vaccaro is a Internal Medicine healthcare provider based in Bradford, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1942262563.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Peter Vaccaro has received a total of $123.19 in payments from pharmaceutical and medical device companies, with $39.05 received in 2020. These payments were reported across 7 transactions from 4 companies. The most common payment nature is "Food and Beverage" ($123.19).
As a Medicare-enrolled provider, Vaccaro has provided services to 3,590 Medicare beneficiaries, totaling 7,835 services with total Medicare billing of $634,182. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Bradford, PA
- Active Since 04/06/2006
- Last Updated 04/06/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1942262563
Products in Payments
- Gonal-f (Biological) $66.30
- WATCHMAN (Device) $18.71
- Xolair (Biological) $17.84
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Bradford
Dr. Paul Kirsch, M.d, M.D
Internal Medicine — Payments: $11,579
Dr. Jakub Wojcik, Md, MD
Internal Medicine — Payments: $6,687
Fayez Roumani, M.d, M.D
Internal Medicine — Payments: $833.59
Dr. Kamran Saleh, M.d, M.D
Internal Medicine — Payments: $319.18
Dr. John Severinghaus, M.d, M.D
Internal Medicine
Nadeen Hussain, Md, MD
Internal Medicine